What is the recommended dose of nitrofurantoin (antibiotic) for acute cystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Nitrofurantoin for Acute Cystitis

For acute uncomplicated cystitis, prescribe nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days. 1, 2

Standard Dosing Regimen

  • Nitrofurantoin monohydrate/macrocrystals 100 mg orally twice daily for 5-7 days is the IDSA-recommended first-line regimen, with the 5-day course being optimal for balancing efficacy and minimizing adverse effects 3, 1, 2

  • The 5-day regimen achieves clinical cure rates of 88-93% and bacterial cure rates of 81-92%, which is equivalent to trimethoprim-sulfamethoxazole and superior to single-dose fosfomycin 3, 1, 4

  • A high-quality 2018 randomized trial demonstrated that 5-day nitrofurantoin resulted in 70% clinical resolution versus 58% for single-dose fosfomycin (12% absolute difference, P=0.004), confirming nitrofurantoin's superior efficacy 5

Alternative Dosing for Specific Situations

  • Nitrofurantoin macrocrystals 50-100 mg four times daily for 5 days is an alternative formulation recommended by European guidelines, though the twice-daily monohydrate/macrocrystal formulation is preferred for compliance 1, 2

  • For vancomycin-resistant Enterococcus (VRE) cystitis specifically, use 100 mg four times daily 1

Critical Contraindications

  • Do not use nitrofurantoin if creatinine clearance is <60 mL/min according to current FDA labeling, as inadequate urinary drug concentrations prevent bactericidal activity 4

  • However, emerging evidence suggests nitrofurantoin may be effective with CrCl 30-60 mL/min (69% cure rate in one study), though it should be avoided if CrCl <30 mL/min 6

  • Avoid nitrofurantoin if early pyelonephritis is suspected, as it does not achieve adequate tissue concentrations for upper tract infections 1

Common Side Effects to Counsel Patients About

  • Nausea and headache are the most common adverse effects, occurring in 5.6-34% of patients 1, 4

  • Rare but serious hepatotoxicity can occur even after just 5 days of treatment, presenting as acute liver injury with jaundice 7

Key Clinical Pearls

  • The 5-day nitrofurantoin regimen is equivalent to 3-day trimethoprim-sulfamethoxazole in both clinical and microbiological outcomes, making it an excellent fluoroquinolone-sparing option 3, 8

  • Nitrofurantoin maintains excellent activity against multidrug-resistant uropathogens with minimal collateral damage to normal flora, which is why guidelines prioritize it as first-line therapy 1, 2

  • Extended-release formulations (100 mg twice daily) and normal-release formulations (50 mg four times daily) show equivalent efficacy for uncomplicated cystitis, though extended-release may be superior in pregnancy 9

References

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cystitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nitrofurantoin Clinical Efficacy and Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Research

Nitrofurantoin: friend or foe?

BMJ case reports, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.